Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
AIDS Behav ; 28(9): 2875-2886, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-38856846

RESUMEN

Pre-exposure prophylaxis (PrEP) is pivotal in curbing HIV transmission and is integral to the national plan to end the HIV epidemic in the United States (US). Nonetheless, widespread PrEP adoption faces barriers. Telehealth delivery models for PrEP, or telePrEP, can enhance PrEP access and adherence by providing flexible care remotely. This study presents a systematic review of telePrEP programs in the US, aiming to describe model characteristics and summarize clinical, implementation, and equity outcomes. We reviewed studies published from 2012 to 2023. We included articles that described telePrEP systems in the US and measured PrEP care continuum outcomes (awareness, initiation, uptake, adherence) or acceptability of the intervention by program users. Eight articles describing six distinct telePrEP initiatives met our inclusion criteria. Studies described models implemented in community-based, academic, and commercial settings, with most programs using a direct-to-client telePrEP model. Across studies, clients reported high acceptability of the telePrEP programs, finding them easy to use, convenient, and helpful as a tool for accessing HIV prevention services. No programs were offering injectable PrEP at the time these studies were conducted. Data was limited in measuring PrEP retention rates and the reach of services to underserved populations, including Black and Latinx communities, transgender individuals, and cis-gender women. Findings underscore the potential of telePrEP to bolster the reach of PrEP care and address structural barriers to access. As telehealth models for PrEP care gain prominence, future research should concentrate on refining implementation strategies, enhancing equity outcomes, and expanding services to include injectable PrEP.


Asunto(s)
Fármacos Anti-VIH , Continuidad de la Atención al Paciente , Infecciones por VIH , Aceptación de la Atención de Salud , Profilaxis Pre-Exposición , Telemedicina , Femenino , Humanos , Masculino , Fármacos Anti-VIH/administración & dosificación , Continuidad de la Atención al Paciente/organización & administración , Accesibilidad a los Servicios de Salud , Infecciones por VIH/prevención & control , Infecciones por VIH/transmisión , Cumplimiento de la Medicación/estadística & datos numéricos , Aceptación de la Atención de Salud/estadística & datos numéricos , Profilaxis Pre-Exposición/métodos , Profilaxis Pre-Exposición/organización & administración , Profilaxis Pre-Exposición/estadística & datos numéricos , Telemedicina/organización & administración , Telemedicina/estadística & datos numéricos , Estados Unidos
2.
Exp Eye Res ; 126: 51-60, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24780752

RESUMEN

RPE cells are the most actively phagocytic cells in the human body. In the eye, RPE cells face rod and cone photoreceptor outer segments at all times but contribute to shedding and clearance phagocytosis of distal outer segment tips only once a day. Analysis of RPE phagocytosis in situ has succeeded in identifying key players of the RPE phagocytic mechanism. Phagocytic processes comprise three distinct phases, recognition/binding, internalization, and digestion, each of which is regulated separately by phagocytes. Studies of phagocytosis by RPE cells in culture allow specifically analyzing and manipulating these distinct phases to identify their molecular mechanisms. Here, we compare similarities and differences of primary, immortalized, and stem cell-derived RPE cells in culture to RPE cells in situ with respect to phagocytic function. We discuss in particular potential pitfalls of RPE cell culture phagocytosis assays. Finally, we point out considerations for phagocytosis assay development for future studies.


Asunto(s)
Fagocitosis/fisiología , Fagosomas/fisiología , Segmento Externo de las Células Fotorreceptoras Retinianas/fisiología , Animales , Células Cultivadas , Humanos , Modelos Animales , Modelos Biológicos , Transducción de Señal/fisiología , Células Madre/citología
3.
Front Biosci (Elite Ed) ; 16(3): 30, 2024 Sep 24.
Artículo en Inglés | MEDLINE | ID: mdl-39344383

RESUMEN

Flavonoids occur naturally in different types of fruits and vegetables, including tea, cabbage, cauliflower, elderberries, cranberries, red apples, lettuce, pears, spinach, green hot peppers, white and red onions, kale, blueberries, and nuts. Among these flavonoids is quercetin, a potent natural antioxidant and cytotoxic substance with a number of therapeutic functions. Nowadays, quercetin is a common ingredient in many nutraceutical and cosmeceutical products due to its antioxidant properties. Its antibacterial effects and possible action mechanisms have been explored in many studies. From these, it has been established that quercetin stops the activity of numerous Gram-negative and -positive bacteria, fungi, and viruses. This review clarifies the plant sources and extraction methods of quercetin, as well as its medicinal applications as an antibacterial, antifungal, antiviral, and antioxidant agent, with a particular emphasis on the underlying mechanisms of its biological activity. The mechanism of its antimicrobial effect involves damaging the cell membrane-e.g., by changing its permeability, preventing biofilm formation, reducing the mitochondrial expression of virulence factors, and inhibiting protein and nucleic-acid synthesis. Moreover, quercetin has been shown to impede the activity of a variety of drug-resistant bacterial strains, pointing to the possibility of using it as a strong antimicrobial substance against such strains. In addition, it has occasionally been demonstrated that specific structural alterations to quercetin can increase its antibacterial action in comparison to the parent molecule. Overall, this review synthesizes our understanding of the mode of action of quercetin and its prospects for use as a therapeutic material.


Asunto(s)
Antioxidantes , Quercetina , Quercetina/farmacología , Humanos , Antioxidantes/farmacología , Flavonoides/farmacología , Antiinfecciosos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA